{{Rsnum
|rsid=7011
|Gene=CINP
|Chromosome=14
|position=102348705
|Orientation=plus
|GMAF=0.1589
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CINP
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 48.7 | 42.5 | 8.8
| HCB | 83.8 | 16.2 | 0.0
| JPT | 69.9 | 29.2 | 0.9
| YRI | 87.1 | 12.9 | 0.0
| ASW | 82.5 | 17.5 | 0.0
| CHB | 83.8 | 16.2 | 0.0
| CHD | 89.9 | 10.1 | 0.0
| GIH | 61.4 | 37.6 | 1.0
| LWK | 81.8 | 17.3 | 0.9
| MEX | 67.2 | 29.3 | 3.4
| MKK | 55.5 | 39.4 | 5.2
| TSI | 47.1 | 41.2 | 11.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=21859556
|Title=Association Study of Selected Genetic Polymorphisms and Occurrence of Venous Thromboembolism in Patients With Multiple Myeloma Who Were Treated With Thalidomide
}}

{{GET Evidence
|gene=CINP
|aa_change=Arg164His
|aa_change_short=R164H
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7011
|overall_frequency_n=2490
|overall_frequency_d=10758
|overall_frequency=0.231456
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|pph2_score=0.02
|nblosum100=1
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}